Continuous glucose monitoring (CGM) is increasingly being used to collect and evaluate data on glycaemic control for research purposes. However, the use of CGM in research settings requires proper understanding and handling of these devices for correct data collection and interpretation.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
European Medicines Agency. Clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus - scientific guideline. ema.europa.eu, https://www.ema.europa.eu/en/clinical-investigation-medicinal-products-treatment-or-prevention-diabetes-mellitus-scientific-guideline (2023).
Battelino, T. et al. Lancet Diabetes Endocrinol 11, 42–57 (2023).
Danne, T. et al. Diabetes Care 40, 1631–1640 (2017).
Vigers, T. et al. PLoS ONE 14, e0216851 (2019).
Riddlesworth, T. D. et al. Diabetes Technol. Ther. 20, 314–316 (2018).
Battelino, T. et al. Diabetes Care 42, 1593–1603 (2019).
Holt, R. I. G. et al. Diabetologia 64, 2609–2652 (2021).
Jackson, M. A., Ahmann, A. & Shah, V. N. Diabetes Technol. Ther. 23, S27–S34 (2021).
Food and Drug Administration, Center for Drug Evaluation and Research. Diabetes mellitus: efficacy endpoints for clinical trials investigating antidiabetic drugs and biological products; draft guidance for industry. regulations.gov, https://www.regulations.gov/docket/FDA-2023-D-0625 (2023).
Cichosz, S. L., Jensen, M. H. & Hejlesen, O. J. Diabetes Sci. Technol. 17, 690–695 (2023).
Lachin, J. M., Bebu, I., Gao, X., Nathan, D. M. & Zinman, B. Diabetes Care 45, 2445–2448 (2022).
Divilly, P. et al. Diabet. Med. 39, e14892 (2022).
Barua, S. et al. EClinicalMedicine 35, 100853 (2021).
Sofizadeh, S., Pehrsson, A., Ólafsdóttir, A. F. & Lind, M. J. Diabetes Sci. Technol. 16, 373–382 (2022).
Vettoretti, M., Cappon, G., Acciaroli, G., Facchinetti, A. & Sparacino, G. J. Diabetes Sci. Technol. 12, 1064–1071 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
UZ Leuven received non-financial support for travel from Novo Nordisk, and Boehringer-Ingelheim for M.M.V. M.M.V. serves or has served on the speakers bureau for Dexcom — financial compensation for these activities has been received by KU Leuven. P.G. serves or has served on the advisory panel for Novo Nordisk, Sanofi-Aventis, Boehringer-Ingelheim, Janssen Pharmaceuticals, Roche, Medtronic, Abbott and Bayer. Financial compensation for these activities has been received by KU Leuven. P.G. serves or has served on the speakers bureau for Merck Sharp and Dohme, Boehringer-Ingelheim, Bayer, Medtronic, Insulet, Novo Nordisk, Abbott, Roche, VitalAire and Dexcom. Financial compensation for these activities has been received by KU Leuven. KU Leuven received for P.G. non-financial support for travel from Sanofi-Aventis, A. Menarini Diagnostics, Novo Nordisk, Medtronic, and Roche. All disclosures were unrelated to the present work.
Peer review
Peer review information
Nature Metabolism thanks the anonymous reviewers for their contribution to the peer review of this work.
Rights and permissions
About this article
Cite this article
Visser, M.M., Gillard, P. Best practices in collecting and reporting continuous glucose monitoring data in research settings. Nat Metab 6, 189–191 (2024). https://doi.org/10.1038/s42255-024-00973-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-024-00973-5
